Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.
| Title | Intravitreal bevacizumab for peripapillary choroidal neovascular membranes. |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Davis, Andrew S., Folk James C., Russell Stephen R., Sohn Elliott H., Sohn Elliot H., H Boldt Culver, Stone Edwin M., and Mahajan Vinit B. |
| Journal | Arch Ophthalmol |
| Volume | 130 |
| Issue | 8 |
| Pagination | 1073-5 |
| Date Published | 2012 Aug |
| ISSN | 1538-3601 |
| Keywords | Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization, Female, Fluorescein Angiography, Humans, Intravitreal Injections, Macular Degeneration, Male, Middle Aged, Retreatment, Subretinal Fluid, Tomography, Optical Coherence, Treatment Outcome, Vascular Endothelial Growth Factor A, Visual Acuity |
| DOI | 10.1001/archophthalmol.2012.465 |
| Alternate Journal | Arch. Ophthalmol. |
| PubMed ID | 22893085 |
